AllCourtTENNIS
GLP-1 Novice
🚫No Source Discussion🚫
Nature article on SYNCHRONIZE-MASLD
48 week study showed 12% mean loss with some specific improvement in liver fat. However, about 20% of participants discontinued because of gastrointestinal side effects.
Zealand stock is down ~25% but markets are still open in Europe .
48 week study showed 12% mean loss with some specific improvement in liver fat. However, about 20% of participants discontinued because of gastrointestinal side effects.
Zealand stock is down ~25% but markets are still open in Europe .
Last edited:
